These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. A Soluble Epoxide Hydrolase Inhibitor, 1-TrifluoromethoxyPhenyl-3-(1-Propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis. Jonnalagadda D; Wan D; Chun J; Hammock BD; Kihara Y Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925035 [TBL] [Abstract][Full Text] [Related]
11. Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice. Zhou Y; Yang J; Sun GY; Liu T; Duan JX; Zhou HF; Lee KS; Hammock BD; Fang X; Jiang JX; Guan CX Cell Tissue Res; 2016 Feb; 363(2):399-409. PubMed ID: 26310139 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys. Ulu A; Appt S; Morisseau C; Hwang SH; Jones PD; Rose TE; Dong H; Lango J; Yang J; Tsai HJ; Miyabe C; Fortenbach C; Adams MR; Hammock BD Br J Pharmacol; 2012 Mar; 165(5):1401-12. PubMed ID: 21880036 [TBL] [Abstract][Full Text] [Related]
13. Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats. Islam O; Patil P; Goswami SK; Razdan R; Inamdar MN; Rizwan M; Mathew J; Inceoglu B; Stephen Lee KS; Hwang SH; Hammock BD Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28296232 [TBL] [Abstract][Full Text] [Related]
14. Functional MRI for characterization of renal perfusion impairment and edema formation due to acute kidney injury in different mouse strains. Tewes S; Gueler F; Chen R; Gutberlet M; Jang MS; Meier M; Mengel M; Hartung D; Wacker F; Rong S; Hueper K PLoS One; 2017; 12(3):e0173248. PubMed ID: 28319118 [TBL] [Abstract][Full Text] [Related]
15. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy]. Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518 [TBL] [Abstract][Full Text] [Related]
16. Renoprotective effects of combined endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 in acute and chronic experimental renal damage. Sharkovska Y; Kalk P; von Websky K; Relle K; Pfab T; Alter M; Fischer Y; Hocher B Clin Lab; 2011; 57(7-8):507-15. PubMed ID: 21888014 [TBL] [Abstract][Full Text] [Related]
17. Renal mechanisms contributing to the antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats with inducible hypertension. Honetschlägerová Z; Husková Z; Vaňourková Z; Sporková A; Kramer HJ; Hwang SH; Tsai HJ; Hammock BD; Imig JD; Červenka L; Kopkan L J Physiol; 2011 Jan; 589(Pt 1):207-19. PubMed ID: 21078594 [TBL] [Abstract][Full Text] [Related]
18. Peripheral soluble epoxide hydrolase inhibition reduces hypernociception and inflammation in albumin-induced arthritis in temporomandibular joint of rats. Teixeira JM; Abdalla HB; Basting RT; Hammock BD; Napimoga MH; Clemente-Napimoga JT Int Immunopharmacol; 2020 Oct; 87():106841. PubMed ID: 32736189 [TBL] [Abstract][Full Text] [Related]
19. TPPU enhanced exercise-induced epoxyeicosatrienoic acid concentrations to exert cardioprotection in mice after myocardial infarction. Guo Y; Luo F; Zhang X; Chen J; Shen L; Zhu Y; Xu D J Cell Mol Med; 2018 Mar; 22(3):1489-1500. PubMed ID: 29265525 [TBL] [Abstract][Full Text] [Related]
20. Effects of vasodilatory antihypertensive agents on endothelial dysfunction in rats with ischemic acute renal failure. Kakoki M; Hirata Y; Hayakawa H; Suzuki E; Nagata D; Nishimatsu H; Kimura K; Goto A; Omata M Hypertens Res; 2000 Sep; 23(5):527-33. PubMed ID: 11016809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]